Welcome to Multibagg AI
Log in to access personalized features
Discovery themes featuring this stockBearish
6
Neutral
4
Bullish
4
Bearish
6
Neutral
8
Bullish
32
Bearish
0
Neutral
4
Bullish
28
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Dashboard
Portfolio
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
IT - Software
Computers - Software & Consulting
64 Cr
Low Risk
-1,583.3
18.5
—
8.0
63.33
1.90
Sales CAGR
Profit CAGR
ROE
ROCE
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Covidh Technologies Ltd (COVIDH) is currently trading at 75.64 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Covidh Technologies Ltd operates in the its sector sector. Review the About Company section on this page to understand its business model, revenue streams, and key products or services.
Over the past 52 weeks, Covidh Technologies Ltd has traded between a low of ₹1.90 and a high of ₹63.33. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Covidh Technologies Ltd has a market capitalization of approximately 63.61. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Covidh Technologies Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -1583.25 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 63.61 Cr, Covidh Technologies Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Covidh Technologies Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Covidh Technologies Ltd is -1583.25. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
77.10 | 76 Cr | 17.06 | 2.49 | 0.00 | 13.72 | 18.09 | 10.24 | ||
12.60 | 74 Cr | 40.65 | 1.62 | 2.33 | 3.32 | 8.42 | 1.00 | ||
2.00 | 71 Cr | -5.72 | 0.58 | 0.00 | 3.79 | 4.04 | 1.83 | ||
29.94 | 65 Cr | 35.22 | 0.70 | 0.00 | 0.71 | 0.64 | 0.98 | ||
63.33 | 64 Cr | -1583.25 | 7.97 | 0.00 | -143.89 | 10.14 | -3.87 | ||
31.65 | 59 Cr | -6.49 | 0.87 | 0.00 | -22.54 | -3.37 | -5.32 | ||
87.70 | 52 Cr | -257.94 | 0.71 | 2.47 | 0.32 | -0.90 | -4.99 | ||
| Median: 7 Co. | — | 31.65 | 65 Cr | -5.72 | 0.87 | 0.00 | 0.71 | 4.04 | 0.98 |
Postal Ballot Notice
iSERA Lifesciences seeks shareholder approval via postal ballot (remote e‑voting Apr 22–May 21, 2026) to increase authorised capital to Rs.25 crore, adopt new MOA/AOA, enhance Section 186 limits, approve acquisition of iSERA Biological by share‑swap and issue shares on preferential basis.
Related Party Acquisition
Board approved increase in authorised capital to Rs25 crore, adoption of new MOA/AOA, enhancement of Section 186 limit to Rs1,000 crore, and a 1:1 preferential share-swap to acquire iSERA Biological at Rs48.20/share, subject to shareholder approval.
Preferential Share-swap
Board approved acquisition of up to 16,182,800 shares (100%) of iSERA Biological via a 1:1 preferential share-swap at Rs.48.20/share (consideration ~Rs78 crore); authorised capital increase, new MOA/AOA, and Section 186 limit hike; shareholder approval to be sought.
Preferential Share Swap
Board approved acquisition of up to 1,61,82,800 shares (100% of iSERA Biological) via 1:1 share-swap issuing shares at Rs.48.20 each (consideration Rs.78,00,10,960), approved authorised capital increase, new MOA/AOA and raising Section 186 limit to Rs1,000 Cr; member approval via postal ballot.
Capital Increase & Acquisition
Board approved increase in authorised share capital from Rs.11 Cr to Rs.25 Cr, adoption of new MOA/AOA, enhancement of Section 186 limit to Rs.1,000 Cr, and approval to acquire 100% of iSERA Biological via 1:1 share-swap (1,61,82,800 shares at Rs.48.20) — all subject to shareholder approval by postal ballot/remote e‑voting.
Share swap acquisition
Board approved acquisition of up to 100% of iSERA Biological (1,61,82,800 shares) via 1:1 share swap at Rs.48.20/share (total consideration Rs.78.00 Cr), increase in authorised capital and related approvals; subject to postal ballot.
